# BEXLUTRY
> **NDA218525** · New Drug Application · Sponsor: CURIUM · Approved 2026-09-14
## Drug
- **FDA Application Number:** NDA218525
- **Application type:** New Drug Application
- **Brand name:** BEXLUTRY
- **Generic name:** Lutetium Lu-177 Dotatate
- **Active ingredients:** LUTETIUM LU-177 DOTATATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** CURIUM
- **First approval:** 2026-09-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218525)
---
*MORVS · CC0 1.0*